We had previously shown that G7-peptides were able to disrupt Grb7 interactions with upstream binding partners, but it was not yet known whether the second generation peptides possess improved anti-cancer activity over G7-18NATE-Pen [32]. This evidence concerns the gene GRB7 and cancer.